180 related articles for article (PubMed ID: 37527777)
1. Colorectal cancer-associated mutations impair EphB1 kinase function.
Kim Y; Ahmed S; Miller WT
J Biol Chem; 2023 Sep; 299(9):105115. PubMed ID: 37527777
[TBL] [Abstract][Full Text] [Related]
2. Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer.
Mathot L; Kundu S; Ljungström V; Svedlund J; Moens L; Adlerteg T; Falk-Sörqvist E; Rendo V; Bellomo C; Mayrhofer M; Cortina C; Sundström M; Micke P; Botling J; Isaksson A; Moustakas A; Batlle E; Birgisson H; Glimelius B; Nilsson M; Sjöblom T
Cancer Res; 2017 Apr; 77(7):1730-1740. PubMed ID: 28108514
[TBL] [Abstract][Full Text] [Related]
3. Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis.
Huynh-Do U; Vindis C; Liu H; Cerretti DP; McGrew JT; Enriquez M; Chen J; Daniel TO
J Cell Sci; 2002 Aug; 115(Pt 15):3073-81. PubMed ID: 12118063
[TBL] [Abstract][Full Text] [Related]
4. Phosphatase and tensin homolog regulates stability and activity of EphB1 receptor.
Rodriguez S; Huynh-Do U
FASEB J; 2013 Feb; 27(2):632-44. PubMed ID: 23118026
[TBL] [Abstract][Full Text] [Related]
5. Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells.
Kundu S; Nunes L; Adler J; Mathot L; Stoimenov I; Sjöblom T
Cell Commun Signal; 2023 Dec; 21(1):354. PubMed ID: 38102712
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 is required for signaling and membrane targeting of EphB1 receptor tyrosine kinase.
Vihanto MM; Vindis C; Djonov V; Cerretti DP; Huynh-Do U
J Cell Sci; 2006 Jun; 119(Pt 11):2299-309. PubMed ID: 16723736
[TBL] [Abstract][Full Text] [Related]
7. EphB1-mediated cell migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118.
Vindis C; Teli T; Cerretti DP; Turner CE; Huynh-Do U
J Biol Chem; 2004 Jul; 279(27):27965-70. PubMed ID: 15107421
[TBL] [Abstract][Full Text] [Related]
8. Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway.
Fasen K; Cerretti DP; Huynh-Do U
Traffic; 2008 Feb; 9(2):251-66. PubMed ID: 18034775
[TBL] [Abstract][Full Text] [Related]
9. Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.
Teng L; Nakada M; Furuyama N; Sabit H; Furuta T; Hayashi Y; Takino T; Dong Y; Sato H; Sai Y; Miyamoto K; Berens ME; Zhao SG; Hamada J
Neuro Oncol; 2013 Dec; 15(12):1710-20. PubMed ID: 24121831
[TBL] [Abstract][Full Text] [Related]
10. EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis.
Vindis C; Cerretti DP; Daniel TO; Huynh-Do U
J Cell Biol; 2003 Aug; 162(4):661-71. PubMed ID: 12925710
[TBL] [Abstract][Full Text] [Related]
11. Nck recruitment to Eph receptor, EphB1/ELK, couples ligand activation to c-Jun kinase.
Stein E; Huynh-Do U; Lane AA; Cerretti DP; Daniel TO
J Biol Chem; 1998 Jan; 273(3):1303-8. PubMed ID: 9430661
[TBL] [Abstract][Full Text] [Related]
12. EphB1 associates with Grb7 and regulates cell migration.
Han DC; Shen TL; Miao H; Wang B; Guan JL
J Biol Chem; 2002 Nov; 277(47):45655-61. PubMed ID: 12223469
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization.
Bhatia S; Baig NA; Timofeeva O; Pasquale EB; Hirsch K; MacDonald TJ; Dritschilo A; Lee YC; Henkemeyer M; Rood B; Jung M; Wang XJ; Kool M; Rodriguez O; Albanese C; Karam SD
Oncotarget; 2015 Apr; 6(11):8929-46. PubMed ID: 25879388
[TBL] [Abstract][Full Text] [Related]
14. Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis.
Wang JD; Dong YC; Sheng Z; Ma HH; Li GL; Wang XL; Lu GM; Sugimura H; Jin J; Zhou XJ
Oncology; 2007; 73(3-4):238-45. PubMed ID: 18424888
[TBL] [Abstract][Full Text] [Related]
15. EphB1 is underexpressed in poorly differentiated colorectal cancers.
Sheng Z; Wang J; Dong Y; Ma H; Zhou H; Sugimura H; Lu G; Zhou X
Pathobiology; 2008; 75(5):274-80. PubMed ID: 18931529
[TBL] [Abstract][Full Text] [Related]
16. Aberrant cell segregation in the craniofacial primordium and the emergence of facial dysmorphology in craniofrontonasal syndrome.
Niethamer TK; Teng T; Franco M; Du YX; Percival CJ; Bush JO
PLoS Genet; 2020 Feb; 16(2):e1008300. PubMed ID: 32092051
[TBL] [Abstract][Full Text] [Related]
17. Paradoxes of the EphB1 receptor in malignant brain tumors.
Wei W; Wang H; Ji S
Cancer Cell Int; 2017; 17():21. PubMed ID: 28194092
[TBL] [Abstract][Full Text] [Related]
18. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells.
Cortina C; Palomo-Ponce S; Iglesias M; Fernández-Masip JL; Vivancos A; Whissell G; Humà M; Peiró N; Gallego L; Jonkheer S; Davy A; Lloreta J; Sancho E; Batlle E
Nat Genet; 2007 Nov; 39(11):1376-83. PubMed ID: 17906625
[TBL] [Abstract][Full Text] [Related]
19. Sumoylation of EphB1 Suppresses Neuroblastoma Tumorigenesis via Inhibiting PKCγ Activation.
Chen Q; Deng R; Zhao X; Yuan H; Zhang H; Dou J; Chen R; Jin H; Wang Y; Huang J; Yu J
Cell Physiol Biochem; 2018; 45(6):2283-2292. PubMed ID: 29550816
[TBL] [Abstract][Full Text] [Related]
20. Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrins.
Huynh-Do U; Stein E; Lane AA; Liu H; Cerretti DP; Daniel TO
EMBO J; 1999 Apr; 18(8):2165-73. PubMed ID: 10205170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
